Triple test (second trimester prenatal screening, 14+0 to 20+6 weeks)
The triple test is a second-trimester biochemical prenatal screening test, done between 14+0 and 20+6 weeks of pregnancy. It measures AFP, beta-hCG and unconjugated oestriol in the mother's blood and, together with the mother's details and the exact stage of pregnancy, estimates the risk of trisomies 21 and 18 and of open neural tube defects.
Preparation and sampling
- Preparation
- Guide to preparing for tests
- Sample
- Blood
- Where it is done
- All laboratories and map
Description
About the test
The triple test is a second-trimester prenatal screening test, done between 14+0 and 20+6 weeks of pregnancy. Three biochemical markers are measured in the mother's blood:
- AFP (alpha-fetoprotein) – a protein made by the baby; in the mother's blood it is usually low in trisomies 21 and 18 and raised in open neural tube defects (for example spina bifida) and abdominal wall defects in the baby, but also in multiple pregnancy or when the stage of pregnancy has been estimated incorrectly.
- Beta-hCG (human chorionic gonadotrophin) – a placental hormone; its levels are usually raised in trisomy 21 and low in trisomy 18.
- Unconjugated oestriol (uE3) – a hormone produced jointly by the placenta and the baby (the baby's adrenal glands and liver); its levels are usually low in trisomies 21 and 18.
The marker values are expressed in MoM (multiples of the median, that is, relative to the value expected for the same stage of pregnancy) and, together with the mother's details and the exact stage of pregnancy, are entered into a program that calculates the individual risk of trisomy 21 (Down syndrome) and trisomy 18 (Edwards syndrome). The AFP value is also used to assess the risk of open neural tube defects.
No single marker is reliable enough, because values in unaffected pregnancies and in pregnancies with chromosomal conditions overlap considerably; only the combination of the three markers with the mother's details gives an individual risk estimate. The result is a statistical estimate, not a diagnosis: it shows which women should be offered further tests. First-trimester screening (the double test with an ultrasound measurement of nuchal translucency) and NIPT are more reliable, so second-trimester screening is used mainly when first-trimester screening has not been done.
When it is recommended
- women who did not have first-trimester screening (between 11+0 and 13+6 weeks) or were too late for it;
- pregnant women of any age, especially those aged 35 or over;
- women who had a previous pregnancy with a chromosomal condition;
- cases where an ultrasound scan shows signs that may point to a problem in the baby, as assessed by the doctor.
Preparation
- You do not need to fast.
- Bring the ultrasound report on which the stage of pregnancy was based (with the date of the scan and the measurements), as the exact stage of pregnancy is the most important information for the risk calculation.
- Have ready the details used in the calculation: date of birth, weight, number of babies, smoking, diabetes, whether the pregnancy was conceived through IVF (and whether a donor egg was used) and whether you have had a previous pregnancy with a chromosomal condition.
- If you take high-dose biotin supplements (vitamin B7, common in hair and nail products), tell the laboratory; with high doses a break of 2–3 days is usually needed.
Sample
Venous blood (serum).
Interpreting the results
The result is expressed as an individual risk for each condition tested (for example 1:250 or 1:1000) and compared with the cut-off used by the risk calculation program.
- Low risk – a low probability of the chromosomal conditions covered by the test, although they are not completely ruled out.
- High risk – a higher probability of trisomy 21 or 18; further tests are needed, such as NIPT or a diagnostic test on amniotic fluid (amniocentesis).
- Raised AFP – the doctor usually recommends a detailed ultrasound scan of the baby.
Your doctor interprets the result together with your symptoms and other findings.
What can affect the result
- an incorrectly estimated stage of pregnancy;
- multiple pregnancy;
- the mother's body weight (obesity), diabetes and smoking;
- pregnancy conceived through IVF;
- errors in the data entered into the risk calculation program.
Related tests
- NIPT (non-invasive prenatal test on the mother's blood);
- detailed fetal anomaly ultrasound scan;
- amniocentesis, for diagnostic confirmation;
- genetic counselling.
Frequently ordered together
How to order tests online?
Choose the tests you need and add them to your cart. Use the site search to find the tests you want more easily.
Payment method:
- Online – payment uses 3D-Secure, a secure authentication protocol that minimises the risk of fraud.
- At the laboratory – order your tests online and pay for them when you come to the laboratory.
After payment, you will receive an email confirming your order, with details of how to prepare for sampling. From then on, you can go to the Sante laboratory you chose when ordering your tests and have your samples taken.